
Glyparamide
CAS No. 5581-42-0
Glyparamide( —— )
Catalog No. M33220 CAS No. 5581-42-0
Glyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGlyparamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.
-
DescriptionGlyparamide is an orally active chlorophenyl-containing sulfonylurea. Glyparamide shows hypoglycemic activity and rarely causes hepatic injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5581-42-0
-
Formula Weight353.82
-
Molecular FormulaC15H16ClN3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 55 mg/mL (155.45 mM; Ultrasonic )
-
SMILESO=C(NC1=CC=C(C=C1)N(C)C)NS(=O)(=O)C2=CC=C(Cl)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuntao Liu, et al. Emerging Theranostic Nanomaterials in Diabetes and Its Complications. Adv Sci (Weinh). 2022 Jan;9(3):e2102466.?
molnova catalog



related products
-
Raffinose(b)
Raffinose is a natural compound.
-
Aminomalonic acid
Aminomalonic acid (Ama) was first detected in alkaline hydrolysates of proteins in 1984. Ama has been isolated from proteins of Escherichia coli and human atherosclerotic plaque. The presence of Ama has important biological implications because the malonic acid moiety potentially imparts calcium binding properties to protein.
-
D-Fructose-16-diphos...
Fosfructose trisodium is a cytoprotective natural sugar phosphate for the potential treatment of sickle cell anemia cardiovascular ischemia and asthma. It acts by stimulating anaerobic glycolysis which generates adenosine triphosphate under ischemic conditions.